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2570Objective: The purpose of the present study was to study the midterm hemodynamic outcomes of unidirectional
valved patch closure of ventricular septal defects (VSDs) in patients with VSD and pulmonary arterial hyper-
tension (PAH).
Methods: From January 2006 to January 2012, 20 patients with VSD with PAH and a pulmonary vascular resis-
tance index>8 Wood units underwent VSD closure with a unidirectional valved patch using the technique pre-
viously described by us. Of these, 13 patients agreed to follow-up cardiac catheterization and were studied at a
mean follow-up of 34.7  18.6 months (range, 2-56). The mean age of these 13 patients was 8.5  4.4 years
(range, 2-19; median, 9), and the mean preoperative systemic saturation was 94.1% 3.4% (range, 87-99; me-
dian, 95.0) The mean preoperative pulmonary artery systolic pressure was 96.2  13.6 mm Hg (range, 75-115;
median, 103.0), and the mean preoperative pulmonary vascular resistance index was 10.0  2.1 Wood units
(range, 8.0-15.1; median, 9.3).
Results: At follow-up cardiac catheterization, the mean systemic saturation had increased to 98.92%. The pul-
monary vascular resistance index had decreased significantly to 5.8  2.1 Wood units (P ¼ .02). A significant
decrease was seen in the pulmonary artery systolic, diastolic, and mean pressures (P ¼ .000), and none of the
patients had severe PAH. No patients died, and all patients were in New York Heart Association class I.
Conclusions:Unidirectional valved patch closure of VSD is a promising technique for patients with a large VSD
and severe PAH. It had a favorable effect on the immediate, early, and midterm clinical outcomes and hemody-
namic parameters. (J Thorac Cardiovasc Surg 2014;148:2570-5)It is not uncommon in third world countries to encounter a
patient with a ventricular septal defect (VSD) with severe
pulmonary arterial hypertension (PAH). The treatment of
these patients has been fraught with the early and midterm
adverse effects of longstanding PAH.1,2 Unidirectional
valved patch (UVP) closure of the VSD has been
described as one of the surgical alternatives for such
patients to reduce the early morbidity and mortality and
to possibly prevent right ventricular decompensation in
the mid term.3-8 In our earlier publications, we described
our own method of VSD closure using a UVP5 and its early
and midterm results.9 We now present the detailed hemody-
namic characteristics and cardiac catheterization data from
these patients as objective evidence of the success of this
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The Journal of Thoracic and Cardiovascular SurMETHODS
From January 2006 to January 2012, 20 patients with VSD and a basal
pulmonary vascular resistance (PVR) index (PVRI) of>8 Wood units un-
derwent VSD closure with a UVP using the technique previously described
by Choudhary and colleagues.5 The medical records of these patients were
analyzed and the preoperative characteristics recorded (Table 1). All 20 pa-
tients were contacted and cardiac catheterization was recommended to
document the hemodynamic and oximetry data. Of the 20 patients, 13
agreed to undergo cardiac catheterization. The institutional ethics commit-
tee approved study protocol.
Of the 20 patients for whom preoperative and early results were avail-
able, 12 were male. The mean patient age was 9.4  5.5 years (range, 2-
23; median, 8). Of the 20 patients, 18 were in New York Heart Association
class III at surgery. None of the patients had cyanosis. The preoperative
radiograph showed mild cardiomegaly in 7 patients and no cardiomegaly
in 13 patients, with signs of severe PAH. A bidirectional shunt with a pre-
dominant left to right shunt was seen on the echocardiogram in 18 patients
and 2 patients had a right to left shunt across the VSD. A total of 18 patients
had a perimembranous VSD; 1 of these 18 had an inlet extension of the
VSD. One patient had a muscular VSD and a perimembranous VSD, and
one had 2muscularVSDs. Four patients had a concurrent atrial septal defect
and four had a patent ductus arteriosus. Thesewere repaired simultaneously.
Cardiac Catheterization Protocol
The protocol for cardiac catheterization and hemodynamic and oximetry
data collection was uniform. It consisted of adequate conscious sedation and
analgesia. Right heart catheterization was performed using Swan-Ganz
balloon-tipped catheter, and left heart catheterization was performed using
a pigtail catheter. The pressures were recorded at the chambers, and samples
were collected from the superior vena cava, pulmonary artery, left ventricle,gery c December 2014
Abbreviations and Acronyms
ICU ¼ intensive care unit
PAH ¼ pulmonary arterial hypertension
PAP ¼ pulmonary artery pressure
PVR ¼ pulmonary vascular resistance
PVRI ¼ pulmonary vascular resistance index
Qp ¼ pulmonary blood flow
Qs ¼ systemic blood flow
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Dand aorta. In all patients, high-flow, 100% oxygen was administered using a
face mask for 10 minutes, and samples were again obtained from the same
sites. Oxygen consumption was calculated as the assumed oxygen consump-
tion according to the age, gender, and heart rate of the patient from the stan-
dard normograms. Oximetry and blood gas analysis of the samples was
performed, and, using the Fick principle, the baselinevalues of the pulmonary
blood flow (Qp), systemic blood flow (Qs), PVRI, and indexed systemic
vascular resistance were calculated using standard equations. These indexes
were also calculated after oxygen administration, taking into account the
correction required for dissolved oxygen. The data were recorded and inter-
preted, taking into consideration the clinical status of the patients.
The mean basal preoperative arterial saturation was 94.1%  2.9%
(range, 87%-99%; median, 94.0%), which increased to a mean of
98.7% 1.1% (range, 97%-100%; median, 99.0%) after the administra-
tion of high-flow oxygen for 10minutes. Themean preoperative pulmonary
artery systolic pressure was 96.4  11.9 mm Hg (range, 75-115; median,
100), and the mean pulmonary artery diastolic pressure was 46.4  11.7
mmHg (range, 23-67; median, 45.5). On administration of oxygen, the pul-
monary artery systolic pressure and pulmonary artery diastolic pressure
decreased to 68.2  25.9 mm Hg and 28.8  12.6 mm Hg, respectively.
The mean/Qs ratio was 1.5  0.5 (range, 1.1-3.2; median, 1.40) and
increased to 4.0  0.9 (range, 2.8-6.5) with oxygen administration. The
mean basal PVRI for the 20 patients was 10.9  2.3 Wood units (range,
8.0-16.1; median, 10.05). All patients showed a decrease in the PRVI
with oxygen administration, with a concomitant increase in left to right
shunting. The mean PVRI after oxygen administration was 3.78  1.95
Wood units (range, 1.3-9.8; median, 4.20).
Decision Making
The decision to perform surgery was determined by the referring cardi-
ologist and operating surgeon and acceptance of the surgical risks by the
patient and family, with their informed consent. No absolute value of
PVRI was taken as a cutoff. A combination of clinical findings (ie, age, car-
diomegaly, flow murmurs), chest radiographic findings (ie, cardiomegaly,
pulmonary plethora), and electrocardiographic findings (ie, left ventricular
volume overload and hypertrophy) were used, along with the hemody-
namic data and response to the 10 minutes of oxygen inhalation, to deter-
mine the patient’s operability. As is apparent from the preoperative data of
our patients, a patient with a PVRI as great as 16 underwent surgery. None
of these children had cyanosis clinically, although no exercise test was per-
formed before cardiac catheterization. We did not consider systemic desa-
turation in the basal state at cardiac catheterization alone to be indicative of
operability, because it could have resulted from extra sedation in some
cases and would have normalized with oxygen inhalation.
Management
VSDclosurewas performed using previously reported techniques.5,9 The
interatrial septum was always completely closed in these patients, because a
valved communication had been provided at the level of the VSD. AsThe Journal of Thoracic and Cardetailed in our previous reports,5,9 phenoxybenzamine (1 mg/kg) was
administered at aortic cannulation and was continued postoperatively (1
mg/kg every 8 hours). All patients received dopamine 5 to 10 mg/kg/min,
nitroglycerin or nitroprusside 0.5 to 2 mg/kg/min, or milrinone before
weaning from cardiopulmonary bypass. In the last 10 patients, sildenafil
0.5 mg/kg through the nasogastric tube was started after arrival in the
intensive care unit (ICU). Early extubation was encouraged. After
extubation, oral angiotensin-converting enzyme inhibitors or oral phenoxy-
benzamine and sildenafil were administered, and the inotropes wereweaned
off. The former were continued during the follow-up period indefinitely,
because the optimal therapy duration for these patients is unknown.
Statistical Analysis
Statistical analysis was performed using the Statistical Package for So-
cial Sciences, version 15.0 (SPSS, Inc, Chicago, Ill). Nominal variables are
presented as frequencies and percentages. Parametric data are presented as
the mean  standard deviation. Two levels in the same group were tested
using a paired t test, and intergroup analysis was performed using the inde-
pendent Student t test.
RESULTS
Immediate Postoperative Course
The immediate postoperative course has been previously
described in detail.9 In brief, the mean systemic saturation
at termination of cardiopulmonary bypass was 93.3% 
4.3% (range, 84%-100%; median, 93%). Three patients
(patients 2, 13, and 15; Table 1) had a right to left shunt intra-
operatively on the transesophageal echocardiogram and had
had episodes of systemic desaturation after termination of
cardiopulmonary bypass and in the ICU. None of the patients
required nitric oxide or extracorporeal membrane oxygena-
tion support. No early deaths occurred. The mean duration
of mechanical ventilation was only 7.6  2.7 hours (range,
5-16; median, 7). The mean systemic saturation in the ICU
was 96.3%  4% (range, 87%-100%; median, 98%). The
same 3 patients had episodes of systemic desaturation in
the ICU, with the lowest saturation 87%. These were docu-
mented as being due to a right to left shunt through the
UVPon the transthoracic echocardiogramandweremanaged
by supplemental oxygenwithout requiring the reinstitution of
mechanical ventilation. The inotropeswereweaned off on the
first postoperative day in all patients. Themean ICU stay was
1.9  0.3 days (range, 1-3; median, 2). The mean hospital
stay was 5.1  1.3 days (median, 5; range, 4-10).
Follow-up Data
The mean follow-up was 33 16.8 months (range, 2-56;
median, 36.5). At the last follow-up visit, all 20 patients
were in New York Heart Association class I functional sta-
tus, and none of the patients had cyanosis. The clinical car-
diac examination findings were unremarkable.
Chest Radiographic, Electrocardiographic, and
Echocardiographic Features
The chest radiography of 1 patient (patient 6) showed
mild cardiomegaly of the right ventricular type; all other
patients had a normal cardiac silhouette.diovascular Surgery c Volume 148, Number 6 2571
TABLE 1. Preoperative characteristics of all 20 patients
Pt. No. Age (y) Gender
SpO2 (%)
PVRI
(Wood units)
PASP
(mm Hg)
PADP
(mm Hg)
Qp/Qs
ratio
Ao/LA
Postoperative
course
Last
follow-up
(mo)
Cardiac
catheterizationBasal
After
O2 Basal
After
O2 Basal
After
O2 Basal
After
O2 Basal
After
O2
1 5 F 91 99 9.1 4.3 89 60 45 23 1.4 3.6 21/23 Uneventful 56 Yes
2 7 M 93* 100 16.1 9.8 102 83 54 31 1.1 4.5 20/20 Desaturationy 50 No
3 5 M 94 98 12.6 1.8 85 78 46 25 1.1 3.8 21/24 Uneventful 37 No
4 6 F 97 97 10.6 2.3 92 31 42 12 1.7 4.9 16/32 Uneventful 31 No
5 23 M 96 98 13.2 4.2 110 43 35 35 1.8 2.9 30/38 Uneventful 36 No
6 11 F 96 99 9.3 4.5 110 46 47 19 1.5 3.1 25/27 Uneventful 49 Yes
7 6 M 95 98 8.7 3.2 90 36 34 11 1.2 3.8 16/20 Uneventful 45 Yes
8 10 M 93* 97 13.7 4.5 76 27 34 12 1.7 4.3 23/24 Uneventful 50 Yes
9 13 F 94 99 8.9 1.9 80 30 23 8 1.8 3.5 20/27 Uneventful 37 Yes
10 13 F 94 100 13.3 2.25 102 80 52 34 1.16 4.2 25/29 Uneventful 24 No
11 9 F 95 100 8.7 2.5 104 86 50 40 1.3 5.4 18/42 Uneventful 42 Yes
12 2 M 94 98 10.6 2.5 88 67 45 23 1.4 2.8 18/20 Uneventful 22 No
13 2 M 89 99 9.5 1.3 75 65 40 31 1.1 3.5 19/25 Desaturationy 48 Yes
14 5 F 87 98 9.4 4.2 90 78 66 35 1.2 3.7 19/28 Uneventful 54 Yes
15 9 M 95 99 11.1 5.4 110 92 67 36 1.1 4.5 21/24 Desaturationy 22 Yes
16 15 M 94 98 9.3 4.3 103 76 54 27 1.4 4.1 26/30 Uneventful 27 Yes
17 15 M 91 97 10.8 4.3 98 66 39 34 1.5 3.9 22/27 Uneventful 8 No
18 7 F 96 100 8 1.7 106 104 58 53 2 6.5 25/41 Uneventful 10 Yes
19 5 F 99 100 15.1 5.1 103 102 62 53 1.3 3.9 13/20 Uneventful 9 Yes
20 19 M 98 99 9.2 5.7 115 114 34 34 3.2 3.9 33/35 Uneventful 2 Yes
Patients 1, 2, 4, and 7 had an associated atrial septal defect; patients 9, 11, 13, and 17 had an associated patent ductus arteriosus. Pt. No., Patient number; SpO2, oxygen saturation;
PVRI, indexed pulmonary vascular resistance; PASP, pulmonary arterial systolic pressure; PADP, pulmonary arterial diastolic pressure; Qp, pulmonary blood flow; Qs, systemic
blood flow; Ao, aorta; LA, left atrium; O2, oxygen; F, female; M, male. *Right to left shunt. ySaturation of<92% with room air as measured by pulse oximetry.
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and 20) showed right ventricular hypertrophy, and 2 patients
(patients 9 and 18) had left ventricular hypertrophy.
On the echocardiogram at the last follow-up examina-
tion, no shunt was seen across the UVP through the valve
created in it (either left to right or right to left) in any of
the patients. One patient had a small left to right residual
shunt at the upper margin of the VSD patch. None of the pa-
tients had evidence of poor right ventricular function, and,
except for 1 patient, all patients had normal left ventricular
function. All patients had some degree of insignificant
tricuspid regurgitation that was either mild or less than
mild. The predicted right ventricular systolic pressure as
calculated from the tricuspid regurgitation jet on the echo-
cardiogram was 32.5  8.6 mm Hg (range, 25-45; median,
28). Two patients had mild pulmonary regurgitation.
The electrocardiographic and echocardiographic charac-
teristics of these patients are summarized in Table 2.
Cardiac Catheterization Findings
Cardiac catheterization data were available for 13 pa-
tients who had agreed to undergo cardiac catheterization
at the last follow-up visit (Table 3).
For these 13 patients, the mean age was 8.5  4.4 years
(range, 2-19). The data from 13 patients were not different
from the remainder of the cohort who had not agreed to car-
diac catheterization. The mean follow-up duration between2572 The Journal of Thoracic and Cardiovascular Sursurgery and cardiac catheterization for these patients was
34.7  18.6 months (range, 2-56; median, 42). The mean
preoperative systemic saturation for these patients before
surgery was 94.1%  3.4%, and this had increased to
96.0%  2.04% at the last follow up visit (P ¼ .13).
The mean systolic pulmonary artery pressure (PAP)
showed a significant decrease from 96.2  13.6 mm Hg
in the preoperative period to 39.6  11.5 mm Hg in the
follow-up period (P ¼ .000). A similar and significant
decrease in the diastolic PAP was noted from 47.2  13.8
mm Hg to 13.2  6.9 mm Hg (P ¼ .000). The mean PAP
also showed a significant decline in the follow-up period,
from 51.0  12.9 mm Hg to 24.5  8.5 mm Hg
(P ¼ .000). None of the 13 patients had an increase in the
mean, systolic, or diastolic PAP. When classifying the pa-
tients according to the mean PAP, 4 (30.8%) had no PAH
(mean PAP, 12-20 mm Hg), 6 (46.2%) had mild PAH
(mean PAP, 21 to 29 mm Hg), and 3 (23.1%) had moderate
PAH (mean PAP, 30-49 mm Hg). None of the patients had
severe PAH (mean PAP, 50 mm Hg). This was in contrast
to preoperatively, when all 13 patients had severe PAH
(mean PAP, 50 mm Hg).
The mean Qp/Qs ratio for these patients was 1.5  0.6
(range, 1.1-3.2) before surgery. At the follow-up point,
except for patient 19, who had an increase in the Qp/Qs ra-
tio, all patients had had a decrease in the Qp/Qs ratio
(P ¼ .14).gery c December 2014
TABLE 2. Echocardiographic and electrocardiographic characteristics of patients who agreed to cardiac catheterization
Pt. No.
TR gradient
(mm Hg) Predicted RVSP Pulmonary valve Ao/LA Shunt RV function LV function ECG findings
1 26 43 No PR 21/28 No shunt Normal Normal Normal
6 30 38 No PR 27/25 No shunt Normal Normal RVH
7 20 27 No PR 22/25 No shunt Normal Normal Normal
8 18 25 No PR 24/24 No Shunt Normal Normal Normal
9 20 25 No PR 22/24 No shunt Normal Normal LVH
11 21 26 No PR 20/36 No Shunt Normal Normal Normal
13 20 25 Mild PR 24/24 No shunt Normal Normal RVH
14 34 38 Mild PR 20/22 No shunt Normal Normal Normal
15 18 28 No PR 17/18 No shunt Normal Normal Normal
16 40 45 No PR 20/22 No shunt Normal Normal RVH
18 20 28 No PR 26/33 No shunt Normal Normal LVH
19 20 26 No PR 17/24 No shunt Normal Normal Normal
20 42 48 No PR 25/39 No shunt through patch;
residual shunt at upper end
Normal Mild dysfunction RVH
Pt. No., Patient number; TR, tricuspid regurgitation; RVSP, right ventricular systolic pressure; Ao, aorta; LA, left atrium; RV, right ventricular; LV, left ventricular; ECG, electro-
cardiographic; PR, pulmonary regurgitation; RVH, right ventricular hypertrophy.
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erative period was 10.0  2.1 Wood units (range, 8.0-15.1;
median, 9.3). During follow-up, the PVRI showed a decline
in 12 patients (92.3%) and an increase in 1. The mean PVRI
at rest for the patients at follow-up was 5.8  0.6 Wood
units (P ¼ .02). Thus, closure of the VSD with a UVP
was associated with a significant decrease in the PVRI
(P ¼ .02.). Of the 13 patients, at follow-up, 11 (84.6%)
had a PVRI of <8 Wood units, and only 2 patients
(15.4%) continued to have a PVRI of >8 Wood units
(Figure 1). Of these 2 patients with a continued PVRI at
rest>8 Wood units, 1 had a decrease in the PVRI from
9.3 to 8.3 Wood units, and 1 had a small increase from
the preoperative PVRI of 8 Wood units to 8.2 Wood units.
The trend of the PVRI for all 13 patients is shown inTABLE 3. Postoperative characteristics of patients undergoing cardiac ca
Pt. No. Age (y)
Follow-up
(mo)
Basal
SpO2 (%)
SpO2 with
O2 (%)
PA
(mm
Pre Post Pre Post Pre
1 5 56 91 96 99 100 89
6 11 49 96 97 99 100 110
7 6 45 95 96 98 99 90
8 10 50 93 93 97 99 76
9 13 37 94 95 99 100 80
11 9 42 95 98 100 100 104
13 2 48 89 99 99 99 75
14 5 54 87 97 98 100 90
15 9 22 95 92 99 100 103
16 9 27 95 97 99 100 110
18 7 10 96 96 100 99 106
19 5 9 99 98 100 99 103
20 19 2 98 94 99 97 115
Pt. No., Patient number; SpO2, oxygen saturation; PASP, pulmonary artery systolic pressu
pulmonary blood flow; Qs, systemic blood flow; PVRI, indexed pulmonary vascular resist
The Journal of Thoracic and CarFigure 1, and the hemodynamic profile is depicted in
Figure 2.
DISCUSSION
In patients diagnosed with VSD and PAH, the outcomes
of VSD closure will be dependent on the Heath-Edwards
classification of the changes at closure of such defects.1
The morbidity and mortality of VSD closure in such pa-
tients with PAH has remained high.2,6 Acute pulmonary
hypertensive crisis, right ventricular failure, and
respiratory failure have been the most common causes of
postoperative mortality in such patients. In the study by
Moller and colleagues,10 an elevated PVR>7 Wood units
and age>5 years were important risk factors for death dur-
ing long-term follow-up at 30 years. Closure of defects intheterization
SP
Hg)
PADP
(mm Hg)
Mean PAP
(mm Hg)
Qp/Qs
ratio
PVRI at
rest
Post Pre Post Pre Post Pre Post Pre Post
40 45 10 32 24 1.4 1.2 9.1 6.4
47 47 21 70 33 1.5 0.9 9.3 8.3
48 34 10 56 24 1.2 0.9 8.7 7.7
23 34 8 46 12 1.7 0.7 13.7 1.6
37 23 13 40 19 1.8 0.9 8.9 6.5
39 50 5 50 22 1.3 1 8.7 3.2
30 40 7 32 23 1.1 0.9 9.5 6.1
35 66 10 51 19 1.2 1 9.4 4
32 54 11 46 24 1.4 0.9 9.3 5.6
35 67 10 51 19 1.1 0.9 11.1 6.4
50 58 22 75 33 2 0.8 8 8.2
31 62 15 50 21 1.3 3.2 15.1 3.7
68 34 29 64 46 3.2 1.8 9.2 7.4
re; PADP, pulmonary artery diastolic pressure; PAP, pulmonary artery pressure; Qp,
ance; Pre, preoperative; Post, postoperative.
diovascular Surgery c Volume 148, Number 6 2573
FIGURE 1. Pulmonary vascular resistance index trend in 13 patients un-
dergoing cardiac catheterization 2 to 56 months after closure of the ventric-
ular septal defect using the unidirectional valved patch.
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debated issue, and patients with fixed PVR have been
considered unfit for surgery. However, for those children
in whom the PVR is elevated preoperatively, but reactive,
surgical closure has been reported by Castaneda and
colleague2 and Kanan and colleagues.11 With the advent
of newer pharmacologic and mechanical adjuncts such as
phosphodiesterase inhibitors, inhaled nitric oxide, and
extracorporeal membrane oxygenation, the postoperative
treatment of such patients has become simpler. Experience
with high-dose calcium channel blockers12 and phosphodi-
esterase inhibitors and prostacyclins13 in the successful
treatment of patients with primary pulmonary hypertension
has suggested that in younger children, pulmonary vascular
remodeling could still be a realistic goal. This, along withFIGURE 2. Cardiac catheterization data from 13 patients with ventricular
septal defect and high pulmonary vascular resistance index (PVRI) 2 to 56
months after closure of ventricular septal defect with unidirectional valved
patch. SpO2, Oxygen saturation;O2, oxygen; PASP, pulmonary arterial sys-
tolic pressure; PADP, pulmonary arterial diastolic pressure; mPAP, mean
pulmonary artery pressure; Qp/Qs, pulmonary blood flow/systemic blood
flow (ratio).
2574 The Journal of Thoracic and Cardiovascular Surprevious reports of promising early and intermediate-term
results with closure of the VSDwith a UVP, make it a prom-
ising option in the treatment of patients with an elevated
PVRI.
Simple closure of the VSD in such patients has been
shown to be associated with mortality rates of 13% to
24%.11,14 However, using a fenestrated valved patch,
Novick and colleagues3,4 reported an early mortality of
only 3.6%, and using our own technique that we reported
earlier,5 we did not observe any deaths in our experience,
indicating the benefits of this technique. Moreover, just as
in the experience of Novick et al,3,4 using the UVP,
we were able to minimize the duration of mechanical
ventilatory support that would otherwise be required in
these patients to prevent a pulmonary hypertensive crisis.
Other surgical strategies that have been used with mixed
results in this subset of patients have been previous
pulmonary arterial banding, fenestrated patch closure of
the VSD, and leaving an interatrial communication. All
these techniques have their inherent limitations.9 A UVP,
which was first described by Zhou and colleagues8 and later
modified by Novick and colleagues3,4 and Zhang and
colleagues,8 has been a useful technique in the treatment
of such patients. Although reports of the early and
intermediate-term results of this techniquewidely discussed
the clinical and echocardiographic profile of these pa-
tients,3-5,9 the published data regarding the hemodynamic
and oximetry outcomes of this technique have been
sparse. Of particular interest was the comparison of the
results of the UVP with the results with fenestrated
closure of VSD. Although fenestrated closure of the VSD
has been shown to reduce the early morbidity and
mortality in the setting of acute postoperative right
ventricular decompensation, it carries a small, but
definite, risk of a left to right shunt in the follow-up
period should the PAPs decline substantially. This would
obviously necessitate reoperation or interventional
device closure of the fenestration,15 with the potential to
significantly increase the costs of care. However, with a
UVP, once the PAPs have normalized, the valve simply
closes.
In our study, the average decrease in the PVRI was 42%
at the last follow-up visit. The decrease in the PVRI was
greater in patients with a greater preoperative PVRI. Of
the 2 patients, 1, who still had a PVRI>8 Wood units,
also had an increase in PVRI from a preoperative value of
8.0 to 8.2; however, postoperative interval was only 10
months. The other patient with a high PVRI had no clinical
or echocardiographic evidence of right ventricular dysfunc-
tion. These data are objective evidence of the success of the
UVP technique for closure of the VSD associated with PAH
and a high PVRI.
The results of our study would seem to suggest that
because the reduction in the PAPs and the right ventriculargery c December 2014
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should not be different than those patients without signifi-
cant PAH; however, this remains a hypothesis and cannot
be inferred from the results of the present study. It is not
known whether the changes that would presumably have
occurred in the pulmonary vascular bed would be entirely
reversible, even after closure of the defects at this level of
PVRI; hence, the need for randomized studies with pre-
and postoperative analysis and exercise testing. Also, the
PAPs had decreased but had not yet normalized in several
of our patients; thus, close observation is necessary in the
long term. It is well known that closure of a VSD in inoper-
able patients can also result in an initial decrease in the PAP
to lower than the preoperative values but increases over
time.14 Therefore, a larger randomized study with cardiac
catheterization data and pre- and postoperative analysis
with exercise testing would be required to comment on
this issue.
Study Limitations
A major limitation of our study was that the numbers
were small, and the follow-up period was short. None of
our patients had obvious Eisenmenger syndrome. No exer-
cise testing was used, and the response to other pulmonary
vasodilators was not noted. We did not perform lung biopsy
for any of our patients. Finally, the applicability of this tech-
nique to patients who are clearly inoperable or have Eisen-
menger syndrome is not known.
CONCLUSIONS
The results of our study have shown that in patients with
borderline operability, UVP closure is a viable technique
with promising immediate, early, and midterm results and
a favorable effect on the hemodynamic and oximetry pa-
rameters. For patients with established Eisenmenger syn-
drome, additional evaluation is required to comment on
the utility of UVP closure of VSDs.The Journal of Thoracic and CarReferences
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